SARS-CoV-2 Serology testing launched

28 February 2020

 

Affinity Biomarker Labs has launched a SARS-CoV-2 serology testing service. Utilising fully automated platforms and a quantitative Chemiluminescent immunoassay (not lateral flow or ELISA testing) IgM and IgG levels can be tested in whole blood, serum or plasma.